Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
The DOI matches its Crossref record; 373 of the 373 references it cites were found in a registry or an index.
Abstract
Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and amyotrophic lateral sclerosis. The treatment of the same remains a daunting challenge due to the limited access of therapeutic moieties across the blood–brain barrier. Engineered nanoparticles with a size less than 100 nm provide multifunctional abilities for solving these biomedical and pharmacological issues due to their unique physico‐chemical properties along with capability to cross the blood–brain barrier. Needless to mention, there is a scarcity of review articles summarizing recent developments of various nanomaterials including liposomes, polymeric nanoparticles, metal nanoparticles, and bio‐nanoparticles toward the therapeutic and theranostics applications for various neurodegenerative disorders. Here, a broad spectrum of nanomedicinal approaches to eradicate neurodegenerative disorders is provided, along with a brief account of neuroprotection and neuronal tissue regeneration, current clinical status, issues related to safety, toxicity, challenges, and future outlook.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using nanocarriers like liposomes, nanoparticles, and micelles, radiopharmaceuticals can be protected, ensuring their delicate contents remain intact, while also offering improved compatibility and extended circulation within the body [63].”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [63]
In the citing paper
“Owing to their unique physicochemical properties and inherent ability to penetrate the BBB, engineered NPs with dimensions below 100 nm show considerable promise in addressing a range of biological and pharmacological challenges [65].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [65]
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationPericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Research works printed but not linked: 13
- Birks J. S., 2018, Cochrane Database Syst. Rev., 6, CD001190
- Carlesi C., 2011, Arch. Ital. Biol., 149, 151
- Chen W., 2018, Adv. Mater., 30
- Fu T., 2016, Neural Plast., 2016, 1
- Wang Y. L., 2018, Zhonghua Yixue Zazhi, 98, 2678
- Cummings J., 2017, J. Prev. Alzheimers Dis., 4, 109
- Hickey P., 2011, Drug Des., Dev. Ther., 5, 241
- Fernandez H. H., 2016, npj Parkinson's Dis., 2, 1
- 10.1002/adma.201801362 · DOI · Paper page
- Shin J. W., 2016, Hum. Mol. Genet., 25, 4566
- Sone D., 2019, Mol. Psychiatry
- Yusuf M., 2012, Int. J. Nanomed., 7, 4311
- Carpenter D. O., 2001, Int. J. Occup. Med. Environ. Health, 14, 209
Cited by
Items 101–165 of 165
Manzoor, S. I., Ahanger, I. A., Kamli, M. R., Malik, M. A., & Dar, T. A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148293 · Cited by 6
Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder ( SUD )
Patne, A. Y., Mohapatra, S., & Mohapatra, S. S. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70008 · Cited by 6
Nanotechnology Application and Intellectual Property Right Prospects of Mammalian Cell Culture
Rachamalla, H. K., Mukherjee, A., & Paul, M. K. (2022) · Biochemistry · doi:10.5772/intechopen.99146 · Cited by 6
Self-citationTransducer Materials Mediated Deep Brain Stimulation in Neurological Disorders
Zhao, D. S., Cao, Z., Zhong, G., Shi, L., Xie, J., & Hao, J. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202506050 · Cited by 6
Updates in Pharmacogenetics of Non-Small Cell Lung Cancer
Ruwali, M., Moharir, K. S., Singh, S., Aggarwal, P., & Paul, M. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97498 · Cited by 5
Self-citationLiu, H., Hua, M., Zheng, Q. Y., Gao, Y., & Li, Z. (2023) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.47 · Cited by 5
Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's diseases
Bhandari, M., Tiwari, R. K., Chanda, S., & Bonde, G. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00003-5 · Cited by 5
Nanomaterials for Alzheimer’s disease: emerging strategies in diagnosis and therapy
Na, Y., Bai, J., Zhang, N., Geng, F., & Wang, X. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04281-w · Cited by 5
Suri, K., Ramesh, M., Bhandari, M., Gupta, V., Kumar, V., Govindaraju, T., & Murugan, N. A. (2024) · ChemBioChem · doi:10.1002/cbic.202400224 · Cited by 5
Gadhave, D. G., Kale, V. V., Kade, A. P., Jadhav, O. R., Sugandhi, V. V., Babar, V. B., Khot, S. V., Kokare, C., & Paudel, K. R. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103026 · Cited by 5
Barman, D., Parui, R., Narang, K., Gogoi, R., & Iyer, P. K. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.001 · Cited by 5
Peng, L., Xu, Q., Yin, S., Zhang, Y., Wu, H., Liu, Y., Chen, L., Hu, Y., Yuan, J., Peng, K., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1153319 · Cited by 5
Metal nanoparticles for neurodegenerative diseases
Haque, S., & Patra, C. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00012-5 · Cited by 5
Nguyen, T.-T., Varga, G., Pickett, J. R., Wu, M., Ta, H. T., Xu, Z. P., & Zhang, R. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00829h · Cited by 5
Nanodiagnostics and nanomedicines for neurodegenerative disorders
Sulakhiya, K., Kisku, A., Paliwal, R., Gupta, D., Yadav, Y., Pal, A., & Kumar, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00023-7 · Cited by 4
Nanotechnology-driven approaches for the management of Huntington's disease
Shahrukh, M., Jiba, U., Khan, M. A., Amin, S., Ahmad, F. J., & Hasan, N. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107318 · Cited by 4
Emerging anti-inflammatory nanosystems targeted to the brain
Mahanta, A. K., Gothwal, A., Chaulagain, B., Muolokwu, C. E., Tagoe, B., Lamsal, B., Belin, M. A. F., & Singh, J. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2552103 · Cited by 4
Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy
Mukherjee, A., Madamsetty, V. S., & Mukherjee, S. (2021) · Synthesis lectures on biomedical engineering · doi:10.2200/s01083ed1v01y202103bme061 · Cited by 4
Self-citationHao, Y., Shen, X. Y., Liu, J., Cai, Z., Wang, X., Yang, Z., Chen, F., Dong, B., Wang, R., Du, X., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c03672 · Cited by 4
Nanomedicine: A New Frontier in Drug Delivery Systems
Kadir, A. K. M. S., Prabhakar, P. K., Shemanto, M. U., Sharfaraz, A., Tripura, S., Akhter, E., Urmi, R. A., Kundu, J., & Dutta, T. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-4439-2.ch004 · Cited by 4
Therapeutic Impact of Exosomes on Huntington’s Disease
Nag, S., Ghosh, S., Dey, A., Paul, S., & Raveendra, R. P. (2024) · Springer eBooks · doi:10.1007/978-981-99-8373-5_5 · Cited by 4
Paliwal, R., Chaurasiya, A., Panchal, K., Nayak, P., Parveen, N., & Paliwal, S. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91201-3.00003-7 · Cited by 4
Patne, A. Y., Bagban, I., & Suryawanshi, M. V. (2025) · BioChem · doi:10.3390/biochem5040040 · Cited by 3
Palanisamy, P. V., Vedakumari, S. W., & Pravin, Y. R. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00405-0 · Cited by 3
Novel drug delivery systems in treating epilepsy: An update
Uppal, J., Chawla, A., Rehman, R., Hussain, M. S., Maqbool, M., Chawla, P. A., Mohi-ud-din, R., & Mir, R. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00019-6 · Cited by 3
Curcumin mitigates Aβ33-42 fibril-induced neuronal injury in the hippocampus
Chen, Z., Xia, D., Liang, X., Liu, Q., Li, J., Li, Q., & Dong, M. (2024) · Materials Today Physics · doi:10.1016/j.mtphys.2024.101436 · Cited by 3
Zebrafish models for neurological disorders: a platform for natural product-based drug discovery
Chauhan, A., Raviraj, T., Sobti, R. C., Dutta, A., Shukla, M. K., & Kořínek, M. (2026) · Frontiers in Natural Products · doi:10.3389/fntpr.2025.1679580 · Cited by 3
Huntington's Disease: Pathogenesis, Therapies, and Emerging Technologies
Moazzen, A., Çağlar, E. Ş., & Cevher, E. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i10.6828 · Cited by 3
Nanotechnology: A Promising Approach in Nerve Regeneration
Chaskar, A. C., Azmi, N., Tiwari, A., & Kaur, N. (2022) · Current Nanoscience · doi:10.2174/1573413718666220509125522 · Cited by 2
Recent Developments in the Application of Computer-Aided Drug Design in Neurodegenerative Disorders
Bhattacharya, K., Devanath, B., Das, D., Chanu, N. R., & Bhattacharjee, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6637-0_12 · Cited by 2
Revolutionizing Medicine: The Promise of Camouflage Nanoparticles - A Review
Mohammed, V., & Richard, N. S. (2023) · Current Nanomaterials · doi:10.2174/0124054615273067231011110436 · Cited by 2
Ashour, M. N., Elias, T. R., Rasheed, W. I., El-Toukhya, S., Youness, E. R., Sleem, A. A., ramadan, M. M., Mahmoud, K. F., Yassen, N. N., Abdel-Monem, M., et al. (2024) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2024.251449.8997 · Cited by 2
Biomaterials for Treatments of Neurodegenerative Disorders
Yu, Y. P., & Ding, J. (2026) · Engineering · doi:10.1016/j.eng.2026.06.006 · Cited by 1
Nanozymes for Antioxidant Therapy
Wang, M., Li, Q., Lu, M., Wan, H., He, H., Gu, N., & Zhang, Y. (2023) · Springer eBooks · doi:10.1007/978-981-99-3338-9_5 · Cited by 1
A new era of nanotechnology applied in neurological disease treatments
Pandit, J., Bharti, C., Gupta, S., Munawar, S. M., Sabjan, K. B., Quadri, K., Waziri, A., Salawi, A., & Alam, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00031-2 · Cited by 1
Inorganic nanorods direct neuronal differentiation of bone marrow-derived mesenchymal stem cells
Vemuri, S. K., Banala, R. R., Nethi, S. K., Devraj, V. M., Pavan Kumar, P., Thejaswini Lalittha, C., Indira Devi, M., Gurava, R. A., & Subbaiah, G. P. V. (2023) · Biomedical Materials · doi:10.1088/1748-605x/acd097 · Cited by 1
Nanoparticles – a novel theranostic approach to treat alzheimer’s disease
Bashir, W. Q., & Shahzadi, S. (2022) · Journal of Applied Biotechnology & Bioengineering · doi:10.15406/jabb.2022.09.00312 · Cited by 1
Revolutionizing Lung Cancer Treatment: Recent Breakthroughs in Immunotherapy
Anitha, K., Chenchula, S., Ravula, P., Chikatipalli, R., & Bhatt, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-7141-1_4 · Cited by 1
Analysis of Neurotoxic Effects on the Nervous System Induced by Nanoparticles
Salau, A. K., Shehu, M. S., Dada, S. O., Sorunke, T. A., & Oladiji, A. T. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-3065-4.ch004 · Cited by 1
Advancement in Nanomaterial Synthesis and its Biomedical Applications
Benil, P. B., Rajagopal, R., Alfarhan, A., Arasu, M. V., & Al-Dhabi, N. A. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-80371-1_14 · Cited by 1
Mandadi, S. R., Prasad, V. R., Narendra, V., & Bandla, J. (2024) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.15.3.64 · Cited by 1
Advances in Nanomedicine for Treatment of Neurological Disorders
Sahu, S. K., Gupta, P., Keshri, A. K., Sahu, D. S., & Verma, V. S. V. (2025) · Journal of Pharmacology Genetics and Molecular Biology · doi:10.64062/jpgmb.vol1.issue6.1 · Cited by 1
Neuritogenic Activity of Metal Nanoparticles
Saha, S., Tripathy, S., & Patra, C. R. (2024) · Nanomedicine · doi:10.2217/nnm-2023-0297 · Cited by 1
Nanomedicines and nanovaccines manufacturing
Mahaling, B., Baruah, N., Manthripragada, P., & Dinabandhu, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44579-8.00023-0
Din, Z. U., Khan, Y., Zia, A., Anbreen, N., & Sultan, R. (2023) · Advances In Clinical And Medical Research · doi:10.52793/acmr.2023.4(3)-61
Song, D., Wang, Q., Xu, W., Qiao, Y., Feng, L., & Ling, P. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c08936
Nanobiomaterials and nanocomposites in experimental therapeutics
Sharma, N. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36328-3.00014-0
Porous silicon nanocarriers for the management of neurodegenerative disorders
Kumar, D., Kumar, R., Dutt, S., Kalia, P., Singh, S., Maurya, A., Singh, A. K., Awasthi, R., & Singh, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24802-3.00009-3
Doroudian, M., Rahimian, S., Abbasgholinejad, E., & Najafi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33639-3.00003-9
Integrative Nanomedicine Approaches and Secondary Metabolites in Neurodegenerative Diseases
Çakar, B., Çadirci, C., & Kilic, K. D. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch013
Lin, X., Wei, Z., Dong, X., & Sun, Y. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2026.141317
Nanotechnology-based Therapeutic Approach in Alzheimer's Disease
Goswami, R., Banerjee, P., Sanyal, S., Basu, B., & Rahaman, M. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010011
Nanotherapeutics targeting neuroinflammation
Chaulagain, B., Tagoe, B., Gothwal, A., Mahanta, A. K., Muolokwu, C. E., Lamsal, B., & Singh, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00013-1
Need for nanotherapeutics to combat neurodegenerative disorders
Kumar, S., Kumar, S., Shukla, R., & Saraf, S. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00006-4
Maurya, P., Gupta, P., Shaima, K. A., & Maurya, N. K. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-5464-3.ch020
Novel Applications of Nanotechnology in Diagnosis and Treatment of Neurological Disorders
Karade, S., & Kasekar, N. M. (2025) · International Journal of Community Pharmacy · doi:10.65301/ijcp.2025.6.3.9
Application For Nanotechnology For the Treatment of Brain Diseases and Disorders
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5185-1
Neto, E. L. D. O. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2025.tde-28012026-165716
Mesoporous Silica Nanoparticles for Delivery of Therapeutic Agents in Brain Disorders
Alijanpourtolouti, O. (2025) · Murdoch University Research Portal · doi:10.60867/00000107
Drug Delivery Using Nanocarriers
Davies, C. D. L., & Snipstad, S. (2025) · Wiley eBooks · doi:10.1002/9783527844791.ch16
Nanopartículas y neurodegeneración
Velázquez‐Álvarez, L., & Sánchez, J. D. J. R. (2022) · Revista de Farmacología · doi:10.58713/rf.v1i1.5
NANOTHERAPIES FOLLOWING EXPERIMENTAL SPINAL CORD INJURY
Zamfirov, M., Angelov, D. N., & Μanthou, M. E. (2026) · Veredas do Direito Direito Ambiental e Desenvolvimento Sustentável · doi:10.18623/rvd.v23.7619
Nanoengineering of Polymer Particles for Traversing Bio, Nano Interactions
Hembrom, S., Pandey, S., & Kumari, N. (2026) · Engineering materials · doi:10.1007/978-981-95-3581-1_9
Mukherjee, A., Madamsetty, V. S., & Mukherjee, S. (2021) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-01669-1_1
Self-citationPotential Challenges in Anti-angiogenic Nanotherapies and Conclusion
Mukherjee, S., & Madamsetty, V. S. (2022) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-11284-3_6
Self-citation
Metadata
- Authors
- Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A.
- Affiliations
- Rice University (US)
- Mayo Clinic (US)
- Birla Institute of Technology and Science, Pilani (IN)
- Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center 986025 Nebraska Medical Center Omaha NE 68198‐6025 USA
- University of California, Los Angeles (US)
- Aavishkar Oral Strips Pvt. Ltd. 109/3, IDA, Phase 2, Sector 2, Lane 6, Cherlapally Hyderabad Telangana 500051 India
- Corresponding author
- Mukherjee, Sudip
- Paul, Manash Kumar
- Mukherjee, Anubhab
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-06-16
- Volume
- 30
- Issue
- 35
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W3036302963
- Cited by
- 152
- References
- 371
- Citations by year
- 2026: 12 · 2025: 32 · 2024: 29 · 2023: 24 · 2022: 29 · 2021: 22 · 2020: 4
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Functional Materials (publishedVersion)
- Funders
- Rice University
- University of California, Los Angeles
- Mayo Clinic
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- nanomedicine, neurodegenerative diseases, theranostics, blood-brain barrier, engineered nanoparticles, liposomes, polymeric nanoparticles, metal nanoparticles, bionanoparticles, Alzheimer's disease, Parkinson's disease, Huntington's disease, prion disease, amyotrophic lateral sclerosis, neuroprotection, nanoparticle toxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.